Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Admixture mapping reveals evidence of differential multiple sclerosis risk by genetic ancestry.

Chi C, Shao X, Rhead B, Gonzales E, Smith JB, Xiang AH, Graves J, Waldman A, Lotze T, Schreiner T, Weinstock-Guttman B, Aaen G, Tillema JM, Ness J, Candee M, Krupp L, Gorman M, Benson L, Chitnis T, Mar S, Belman A, Casper TC, Rose J, Moodley M, Rensel M, Rodriguez M, Greenberg B, Kahn L, Rubin J, Schaefer C, Waubant E, Langer-Gould A, Barcellos LF.

PLoS Genet. 2019 Jan 17;15(1):e1007808. doi: 10.1371/journal.pgen.1007808. [Epub ahead of print]

2.

Should our treatment target in MS include the intrathecal plasma cell response?

Giovannoni G, Hawkes C, Levy M, Lechner-Scott J, Waubant E.

Mult Scler Relat Disord. 2019 Jan;27:A1-A2. doi: 10.1016/j.msard.2018.12.039. No abstract available.

PMID:
30642567
3.

Vaccines and disease-modifying treatments.

Waubant E, Giovannoni G, Hawkes C, Levy M.

Mult Scler Relat Disord. 2018 Nov;26:A1-A2. doi: 10.1016/j.msard.2018.10.017. Epub 2018 Oct 24. No abstract available.

PMID:
30573174
4.

Several household chemical exposures are associated with pediatric-onset multiple sclerosis.

Mar S, Liang S, Waltz M, Casper TC, Goyal M, Greenberg B, Weinstock-Guttman B, Rodriguez M, Aaen G, Belman A, Barcellos LF, Rose J, Gorman M, Benson L, Candee M, Chitnis T, Harris Y, Kahn I, Roalsted S, Hart J, Lotze T, Moodley M, Ness J, Rensel M, Rubin J, Schreiner T, Tillema JM, Waldman A, Krupp L, Graves JS, Waubant E; U.S. Network of Pediatric Multiple Sclerosis Centers.

Ann Clin Transl Neurol. 2018 Oct 9;5(12):1513-1521. doi: 10.1002/acn3.663. eCollection 2018 Dec.

5.

Acquisition of Early Developmental Milestones and Need for Special Education Services in Pediatric Multiple Sclerosis.

Aaen G, Waltz M, Vargas W, Makhani N, Ness J, Harris Y, Casper TC, Benson L, Candee M, Chitnis T, Gorman M, Graves J, Greenberg B, Lotze T, Mar S, Tillema JM, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Waldman A, Weinstock-Guttman B, Belman A, Waubant E, Krupp L.

J Child Neurol. 2018 Dec 17:883073818815041. doi: 10.1177/0883073818815041. [Epub ahead of print]

PMID:
30556452
6.

Subclinical Saccadic Eye Movement Dysfunction in Pediatric Multiple Sclerosis.

Yousef A, Devereux M, Gourraud PA, Jonzzon S, Suleiman L, Waubant E, Green A, Graves JS.

J Child Neurol. 2018 Nov 21:883073818807787. doi: 10.1177/0883073818807787. [Epub ahead of print]

PMID:
30463467
7.

Body mass index, but not vitamin D status, is associated with brain volume change in MS.

Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D.

Neurology. 2018 Dec 11;91(24):e2256-e2264. doi: 10.1212/WNL.0000000000006644. Epub 2018 Nov 14.

PMID:
30429274
8.

Puberty onset and pediatric multiple sclerosis activity in boys.

Young B, Waubant E, Lulu S, Graves J.

Mult Scler Relat Disord. 2019 Jan;27:184-187. doi: 10.1016/j.msard.2018.10.014. Epub 2018 Oct 22.

PMID:
30390578
9.

Refining the Nosology of Antigen-Specific Diseases Within the Spectrum of Neuromyelitis Optica.

Levy M, Giovannoni G, Hawkes C, Waubant E.

Mult Scler Relat Disord. 2018 Oct;25:A1-A2. doi: 10.1016/j.msard.2018.09.027. No abstract available.

PMID:
30384960
10.

Heterogeneity in association of remote herpesvirus infections and pediatric MS.

Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, Casper TC, Waldman A, Belman A, Greenberg B, Goyal M, Harris Y, Kahn I, Lotze T, Mar S, Schreiner T, Aaen G, Hart J, Ness J, Rubin J, Tillema JM, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Candee M, Weinstock-Guttman B, Shao X, Barcellos L, James J, Waubant E; US Network of Pediatric MS Centers.

Ann Clin Transl Neurol. 2018 Sep 17;5(10):1222-1228. doi: 10.1002/acn3.636. eCollection 2018 Oct.

11.

Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course.

Nourbakhsh B, Bhargava P, Tremlett H, Hart J, Graves J, Waubant E.

Ann Clin Transl Neurol. 2018 Sep 27;5(10):1211-1221. doi: 10.1002/acn3.637. eCollection 2018 Oct.

12.

Urban air quality and associations with pediatric multiple sclerosis.

Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Charvet L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waldman AT.

Ann Clin Transl Neurol. 2018 Sep 27;5(10):1146-1153. doi: 10.1002/acn3.616. eCollection 2018 Oct.

13.

Detection of HHV-6 and EBV and Cytokine Levels in Saliva From Children With Seizures: Results of a Multi-Center Cross-Sectional Study.

Bartolini L, Piras E, Sullivan K, Gillen S, Bumbut A, Lin CM, Leibovitch EC, Graves JS, Waubant EL, Chamberlain JM, Gaillard WD, Jacobson S.

Front Neurol. 2018 Oct 5;9:834. doi: 10.3389/fneur.2018.00834. eCollection 2018.

14.

Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US.

Krysko KM, Graves J, Rensel M, Weinstock-Guttman B, Aaen G, Benson L, Chitnis T, Gorman M, Goyal M, Krupp L, Lotze T, Mar S, Rodriguez M, Rose J, Waltz M, Charles Casper T, Waubant E; US Network of Pediatric MS Centers.

Neurology. 2018 Nov 6;91(19):e1778-e1787. doi: 10.1212/WNL.0000000000006471. Epub 2018 Oct 17.

PMID:
30333163
15.

Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis.

Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J; PARADIGMS Study Group.

N Engl J Med. 2018 Sep 13;379(11):1017-1027. doi: 10.1056/NEJMoa1800149.

PMID:
30207920
16.

Editors' Welcome.

Hawkes CH, Giovannoni G, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Aug;24:A1-A2. doi: 10.1016/j.msard.2018.08.010. No abstract available.

PMID:
30190056
17.

Is cognitive impairment in multiple sclerosis reversible?

Giovannoni G, Hawkes C, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Jul;23:A1. doi: 10.1016/j.msard.2018.07.007. No abstract available.

PMID:
30049507
18.

Diagnosing and caring for MS in Haiti.

Waubant E, Berkowitz A, Giovannoni G, Hawkes C, Levy M.

Mult Scler Relat Disord. 2018 May;22:A1-A2. doi: 10.1016/j.msard.2018.05.009. No abstract available.

PMID:
29807822
19.

Editors' Welcome: Pregnancy and progressive multifocal leukoencephalopathy.

Levy M, Giovannoni G, Hawkes C, Waubant E.

Mult Scler Relat Disord. 2018 Apr;21:A1-A2. doi: 10.1016/j.msard.2018.03.016. No abstract available.

PMID:
29724377
20.

Early infectious exposures are not associated with increased risk of pediatric-onset multiple sclerosis.

Suleiman L, Waubant E, Aaen G, Belman A, Benson L, Candee M, Chitnis T, Gorman M, Goyal M, Greenberg B, Harris Y, Hart J, Kahn I, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Nourbakhsh B, Rensel M, Rodriguez M, Rose J, Rubin J, Schreiner T, Tillema JM, Waldman A, Weinstock-Guttman B, Casper TC, Waltz M, Graves JS; Network of Pediatric Multiple Sclerosis Centers.

Mult Scler Relat Disord. 2018 May;22:103-107. doi: 10.1016/j.msard.2018.03.015. Epub 2018 Mar 26.

PMID:
29653437
21.

Are the high-costs of MS disease-modifying therapies justified?

Giovannoni G, Hawkes C, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Feb;20:A3-A5. doi: 10.1016/j.msard.2018.02.018. No abstract available.

PMID:
29579631
22.

Editors' Welcome.

Hawkes C, Giovannoni G, Levy M, Waubant E.

Mult Scler Relat Disord. 2018 Feb;20:A1-A2. doi: 10.1016/j.msard.2018.02.017. No abstract available.

PMID:
29579630
23.

Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls.

Leibovitch EC, Lin CM, Billioux BJ, Graves J, Waubant E, Jacobson S.

Mult Scler. 2018 Mar 1:1352458518765654. doi: 10.1177/1352458518765654. [Epub ahead of print]

PMID:
29569515
24.

Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawal.

Chong J, Cohen M, Waubant E.

Mult Scler Relat Disord. 2018 Feb;20:178-180. doi: 10.1016/j.msard.2018.01.025. Epub 2018 Mar 20.

PMID:
29414294
25.

Editors' Welcome.

Giovannoni G, Hawkes C, Levy M, Lublin F, Waubant E.

Mult Scler Relat Disord. 2018 Jan;19:A1-A2. doi: 10.1016/j.msard.2018.01.004. No abstract available.

PMID:
29409600
26.

The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults.

Graves JS, Barcellos LF, Simpson S, Belman A, Lin R, Taylor BV, Ponsonby AL, Dwyer T, Krupp L, Waubant E, van der Mei IAF.

Mult Scler Relat Disord. 2018 Jan;19:161-165. doi: 10.1016/j.msard.2017.10.008. Epub 2017 Oct 14.

27.

Gut microbiome and pediatric multiple sclerosis.

Tremlett H, Waubant E.

Mult Scler. 2018 Jan;24(1):64-68. doi: 10.1177/1352458517737369.

PMID:
29307301
28.

Effect of puberty on multiple sclerosis risk and course.

Waubant E.

Mult Scler. 2018 Jan;24(1):32-35. doi: 10.1177/1352458517737393.

PMID:
29307289
29.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
30.

Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE; Pediatric MS Adherence Study Group.

Qual Life Res. 2018 Apr;27(4):1117. doi: 10.1007/s11136-017-1773-4.

31.

Ovarian aging is associated with gray matter volume and disability in women with MS.

Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A; University of California, San Francisco MS-EPIC Team,, Bacchetti P, Hauser SL, Oksenberg JR.

Neurology. 2018 Jan 16;90(3):e254-e260. doi: 10.1212/WNL.0000000000004843. Epub 2017 Dec 22.

32.

Editors' Welcome.

Waubant E, Giovannoni G, Hawkes C, Lublin F.

Mult Scler Relat Disord. 2017 Nov;18:A1-A2. doi: 10.1016/j.msard.2017.10.016. No abstract available.

PMID:
29141832
33.

Examining the contributions of environmental quality to pediatric multiple sclerosis.

Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E; U.S. Network of Pediatric MS Centers.

Mult Scler Relat Disord. 2017 Nov;18:164-169. doi: 10.1016/j.msard.2017.09.004. Epub 2017 Sep 7.

34.

Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.

Nourbakhsh B, Revirajan N, Waubant E.

Contemp Clin Trials. 2018 Jan;64:67-76. doi: 10.1016/j.cct.2017.11.005. Epub 2017 Nov 4.

PMID:
29113955
35.

Editors' Welcome.

Lublin F, Giovannoni G, Hawkes C, Waubant E.

Mult Scler Relat Disord. 2017 Oct;17:A1-A2. doi: 10.1016/j.msard.2017.09.025. No abstract available.

PMID:
29055486
36.

Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis.

Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant E.

J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):28-33. doi: 10.1136/jnnp-2017-315936. Epub 2017 Oct 9.

37.

Genetic risk factors for pediatric-onset multiple sclerosis.

Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E; Network of Pediatric Multiple Sclerosis Centers.

Mult Scler. 2017 Oct 1:1352458517733551. doi: 10.1177/1352458517733551. [Epub ahead of print]

PMID:
28980494
38.

The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings.

Tremlett H, Waubant E.

Neurotherapeutics. 2018 Jan;15(1):102-108. doi: 10.1007/s13311-017-0574-3. Review.

39.

Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis.

Gajofatto A, Nourbakhsh B, Benedetti MD, Waubant E.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):550-552. doi: 10.1136/jnnp-2017-316911. Epub 2017 Sep 22. No abstract available.

PMID:
28939685
40.

Editors' Welcome.

Hawkes C, Giovannoni G, Lublin F, Waubant E.

Mult Scler Relat Disord. 2017 Aug;16:A1-A2. doi: 10.1016/j.msard.2017.07.015. No abstract available.

PMID:
28755685
41.

Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis.

Zhou Y, Graves JS, Simpson S Jr, Charlesworth JC, Mei IV, Waubant E, Barcellos LF, Belman A, Krupp L, Lucas R, Ponsonby AL, Taylor BV; Ausimmmune/AusLong investigators group.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):864-868. doi: 10.1136/jnnp-2017-315971. Epub 2017 Jul 24.

PMID:
28739605
42.

Psychiatric disorders in children with demyelinating diseases of the central nervous system.

Pakpoor J, Goldacre R, Schmierer K, Giovannoni G, Waubant E, Goldacre MJ.

Mult Scler. 2018 Aug;24(9):1243-1250. doi: 10.1177/1352458517719150. Epub 2017 Jul 5.

PMID:
28675955
43.

The 'Field Hypothesis': rebound activity after stopping disease-modifying therapies.

Giovannoni G, Hawkes C, Waubant E, Lublin F.

Mult Scler Relat Disord. 2017 Jul;15:A1-A2. doi: 10.1016/j.msard.2017.06.005. No abstract available.

PMID:
28641776
44.

Editors' welcome.

Waubant E, Giovannoni G, Hawkes C, Lublin F.

Mult Scler Relat Disord. 2017 May;14:A1-A2. doi: 10.1016/j.msard.2017.04.005. Epub 2017 Apr 21. No abstract available.

PMID:
28619438
45.

Dietary factors and pediatric multiple sclerosis: A case-control study.

Pakpoor J, Seminatore B, Graves JS, Schreiner T, Waldman AT, Lotze TE, Belman A, Greenberg BM, Weinstock-Guttman B, Aaen G, Tillema JM, McDonald JC, Hart J, Ness JM, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Mar S, Kahn I, Rose J, Carmichael SL, Roalstad S, Waltz M, Casper TC, Waubant E; US Network of Pediatric Multiple Sclerosis Centers.

Mult Scler. 2018 Jul;24(8):1067-1076. doi: 10.1177/1352458517713343. Epub 2017 Jun 13.

PMID:
28608728
46.

Clinical Reasoning: A 16-year-old girl with subacute weakness and sensory loss.

Quintanilla-Bordás C, Nourbakhsh B, Strober J, Raffel C, Waubant E.

Neurology. 2017 Jun 6;88(23):e225-e229. doi: 10.1212/WNL.0000000000004010. No abstract available.

PMID:
28583938
47.

Maternal and Perinatal Exposures Are Associated With Risk for Pediatric-Onset Multiple Sclerosis.

Graves JS, Chitnis T, Weinstock-Guttman B, Rubin J, Zelikovitch AS, Nourbakhsh B, Simmons T, Waltz M, Casper TC, Waubant E; Network of Pediatric Multiple Sclerosis Centers.

Pediatrics. 2017 Apr;139(4). pii: e20162838. doi: 10.1542/peds.2016-2838.

48.

Editors' Welcome.

Lublin F, Giovannoni G, Hawkes C, Waubant E.

Mult Scler Relat Disord. 2017 Apr;13:A1. doi: 10.1016/j.msard.2017.03.010. No abstract available.

PMID:
28427712
49.

Impact of an electronic monitoring device and behavioral feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial.

Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE; Pediatric MS Adherence Study Group.

Qual Life Res. 2017 Sep;26(9):2333-2349. doi: 10.1007/s11136-017-1571-z. Epub 2017 Apr 9. Erratum in: Qual Life Res. 2017 Dec 23;:.

50.

Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS.

Gianfrancesco MA, Stridh P, Rhead B, Shao X, Xu E, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Bäärnhielm M, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Metayer C, Schaefer C, Barcellos LF, Waubant E; Network of Pediatric Multiple Sclerosis Centers.

Neurology. 2017 Apr 25;88(17):1623-1629. doi: 10.1212/WNL.0000000000003849. Epub 2017 Mar 29.

Supplemental Content

Loading ...
Support Center